Homechevron_rightAll Peptideschevron_rightRetatrutide

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-retatrutide-20mg

Official Product Data Sheet

Retatrutide (20mg)

Ultra High >99.5% Purity

Vial Contents

20 mg Retatrutide (lyophilized powder)

Includes

3 ml bacteriostatic water for reconstitution

Form

Lyophilized white powder for optimal stability

Purity

≥98%, third-party tested (COA available)

Sequence

Long-acting triple agonist (proprietary structure)

Molecular Formula

C₂₂₃H₃₄₃N₅₃O₇₀S₂

Molecular Mass

~4731 g/mol

CAS No.

2381089-83-2

Solubility

Reconstitute with sterile/bacteriostatic water (3 ml for ~6.67 mg/mL)

Storage

Lyophilized frozen; reconstituted refrigerated at 2–8°C for up to 28 days

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

The ultimate dose for maximum fat destruction—clinical trials show 24% body weight loss, reversed fatty liver, and skyrocketed metabolism.

If you're ready to go all-in on weight loss, this 20mg strength gives you the firepower to drop pounds faster than ever. Retatrutide is the triple-threat agonist hitting GLP-1, GIP, and glucagon for unmatched weight loss and metabolic overhaul.

Phase 3 data is incredible: 24% loss at higher doses, 82% liver fat reduction, massive cardiometabolic gains. The glucagon kick burns calories like crazy—perfect for breaking through plateaus.

Intended Research Use

Delivers 20-24% weight loss in 48 weeks
Shreds visceral fat and fixes liver issues (82% reduction)
Drops HbA1c ~2%, improves all metabolic markers
Burns calories like exercise through glucagon activation

menu_bookScientific Publications

article

N Engl J Med (2023)

Triple–hormone-receptor agonist retatrutide for obesity—a phase 2 trial

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/37366315/

article

Lancet (2023)

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/37364343/

article

Nat Med (2024)

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/38877164/

Maximum Value: The 20mg vial provides the best value per mg for aggressive weight loss protocols. Reconstituted at ~6.67 mg/mL, it allows precise dosing with smaller injection volumes for extended protocols.

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Clinical research suggests combining Retatrutide with complementary peptides can enhance weight management outcomes.

Cagrilintide (5mg vial)

arrow_forward

myo-cagrilintide-5mg

Ultimate satiety + fat burn combo.

AOD-9604 (5mg vial)

arrow_forward

myo-hgh-fragment-aod-9604-5mg

Hits every fat pocket hard.

Semaglutide (5mg vial)

arrow_forward

myo-semaglutide-5mg

Max GLP-1 power for unbeatable loss.

Mazdutide 5mg (5mg vial)

arrow_forward

myo-mazdutide-5mg

Dual GLP-1/glucagon agonist with similar 20–24% weight loss outcomes — compared with Retatrutide in trials exploring dual vs. triple receptor activation.

Survodutide 10mg (10mg vial)

arrow_forward

myo-survodutide-10mg

GLP-1/glucagon dual agonist with particular hepatic fat reduction benefits — studied alongside Retatrutide for overlapping appetite regulation mechanisms.

schedule

Cycling Note: Once-weekly for 12+ weeks (trials to 48 weeks).